ClinicalTrials.gov
public full text
Public Domain
Effect of Preoperative Recombinant Human Erythropoietin on Transfusion Risk in Valvular Heart Surgery
The administration of rhEPO on the one day before cardiac surgery will be effective to decrease the bleeding due to the surgery.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Association Of Red Blood Cell Transfusion With Morbidity And Mortality In Post Cardiac Surgery Patients.#432271
- Investigation of the Transfusion Practices in Surgical Patients in Turkey#829032
- Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients#901193
- Epidemiology of Severe Peroperative Bleeding During Scheduled Surgery#1151129
- Transfusion Triggers in Cardiac Surgery#912394
Record · ID 908445
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive